FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

American Health Packaging buPROPion Hydrochloride Extended Release Recall

buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blis…

American Health Packaging · Columbus, OH

Risk level
Class III
Reported by FDA
Aug 21, 2013
Recall ID
D-892-2013
Check your lot numberHow we source this data

Summary

American Health Packaging recalled buPROPion Hydrochloride Extended Release starting Feb 4, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-892-2013 on Aug 21, 2013. Reason: Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds. Status: Terminated.

Why it was recalled

Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.

Product description

buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01

Lot numbers, UPCs & expiration codes

The following codes are affects by the recall: Lot #114500, Exipration Date 08/2013, repackaging date 12/04/2011.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-892-2013
Classification
Class III
Status
Terminated
Recall initiated
Feb 4, 2013
FDA report date
Aug 21, 2013
Quantity
389 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
American Health Packaging

Original FDA data

Every field from FDA enforcement report D-892-2013, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
65457
Address
2550 John Glenn Ave
Address (line 2)
Suite A
Code information
The following codes are affects by the recall: Lot #114500, Exipration Date 08/2013, repackaging date 12/04/2011.
Postal code
43217-1188
Report date
Aug 21, 2013
Product type
Drugs
Recall number
D-892-2013
Classification
Class III
Recalling firm
American Health Packaging
Product quantity
389 cartons
Termination date
Aug 28, 2013
Reason for recall
Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended Release Tablets, USP 100 mg, 100 count carton, 10 blister cards of 10 individually blistered and labeled tablets, Rx only, Actavis South Atlantic LLC, Packaged and Distributed by: American Health Packaging, Columbus, OH --- NDC 68084-470-01
Distribution pattern
Nationwide
Recall initiation date
Feb 4, 2013
Initial firm notification
Letter
Center classification date
Aug 15, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-892-2013, published Aug 21, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls